CHEK2 and prostate carcinoma: The CHEK2 mutation is linked to colorectal and prostate cancer, but its association with endometrial cancer is unclear, and CHEK2 is involved in DNA double-strand break repair, a dysregulated response may lead to tumorigenesis.